PRESS RELEASE
April 23, 2026
For Talents has joined GENEO Capital Entrepreneur and UI Investissement as an investor in Neftys Pharma to support the family succession and accelerate the group’s growth strategy.
The French group Neftys Pharma, a major player in the distribution of animal health products (730 employees, €555 million in revenue in 2025), welcomes For Talents as a new shareholder, alongside GENEO Capital Entrepreneur and UI Investissement, which are reinvesting in this new funding round to facilitate the family transition and support the company’s growth, particularly internationally.
This initiative by For Talents is part of the transition from Jacques Mignot, the group’s founder, to his son Diego Mignot, currently the CEO, who will assume the presidency effective January 1May May. He thus succeeds his father.
Alongside the Mignot family, For Talents—a family-owned private equity firm whose mission is to ensure a successful generational transition in family businesses—is acquiring a minority stake to support this pivotal new phase for the group, combining investment with guidance for executives navigating the succession process.
For their part, UI Investissement and GENEO Capital—which have held a minority stake in the company for the past four years—are reinvesting through their “Growth Fund” and reaffirming their support for this project, which is now even more focused on international expansion. This new investment demonstrates their confidence in Neftys Pharma’s strategy and its management team.
A family business succession planned as part of the ongoing entrepreneurial initiative
Founded in 1987 by Jacques Mignot, Neftys Pharma has grown based on the belief that distribution plays a central role in creating value in the animal health market. Today, the group is taking a new step forward with the transition to the second generation.
This transition was designed to ensure the continuity of the family business, while establishing a clear governance structure and equipping the group with the resources needed to achieve its future ambitions, particularly on the international stage.
Neftys Pharma, a key player in the animal health sector
Neftys Pharma has established itself as a strategic partner for laboratories and animal health professionals.
Building on its long-standing expertise in logistics, the group has gradually expanded its scope of operations to become a global distribution platform capable of meeting the needs of all its partners.
Today, Neftys Pharma offers a comprehensive range of services covering the entire value chain: logistics, marketing, data, digital solutions, and strategic support for pharmaceutical companies seeking to enter the market. Through this integrated approach, the group works every day to ensure that animal health solutions are accessible to both veterinary professionals and pet owners.
With a presence in eight European countries (France, Portugal, Spain, Belgium, Poland, Croatia, Serbia, and Slovenia) and seven African countries (Morocco, Senegal, Ivory Coast, Nigeria, Burkina Faso, Niger, and Mauritius), the company is pursuing an aggressive growth strategy, as evidenced by several acquisitions made in recent years that have strengthened both its geographic reach and its local market positions.
Neftys Pharma aims to accelerate its internal and external growth through five key strategies:
- Strengthening its position in Europe, particularly in Eastern Europe,
- Expansion into new countries,
- The development of new verticals,
- The development of private-label brands (through acquisition or creation),
- And the expansion of its partnerships with research laboratories.
Neftys Pharma already has a solid infrastructure :
- More than 30 logistics sites in 15 countries,
- More than 71,000 square meters of warehouse space,
- More than 21,000 customers,
- More than 20,000 items,
- More than 730 employees.
A capital structure designed to support succession planning and growth
This new capital structure for Neftys Pharma is designed to facilitate the family succession and support the group's growth strategy.
In this context, Neftys Pharma relies on For Talents, whose specialized approach is designed to ensure a smooth transition between generations while supporting executives in their growth initiatives.
——
“The prospect of growing the group founded by my father is an exciting challenge, especially since this ambition is fully shared by all our teams. We aim to consolidate our position as a leading provider of animal health products and services at the European and international levels. For Talents has emerged as a natural partner: beyond its ability to support our growth, we have found a genuine alignment in our approach—entrepreneurial and family-oriented, dedicated to a long-term vision,” adds Diego Mignot.
“We are very pleased to support the succession of Neftys Pharma from Jacques Mignot to his son Diego Mignot, representing the second generation. As a family-owned private equity firm with a unique model, we support family entrepreneurs at a pivotal moment: their intergenerational succession. We were impressed by Diego’s vision and his ambition to grow this family-owned group,” said Benjamin Teszner, Partner at For Talents.
“In four years, Neftys Pharma has doubled in size, established a presence in numerous European countries, and accelerated its external growth momentum. We are proud to continue supporting the company as it implements this outstanding ‘Growth Roadmap’ and its ambitious impact plan, which balances performance with sustainability,” said François Picarle, Partner at GENEO Capital Entrepreneur.
“UI Investissement’s ambition is to contribute to the development of French companies, and it is also to participate in sovereign projects. “Therefore, supporting a French group—one that is contributing to the European consolidation of such a strategic sector and whose impact extends across generations—is an endeavor that UI Investissement is very pleased not only to have been part of for the past four years, but even more so to continue in the years to come,” adds Stéphanie Pépineau, Associate Director of UI Investissement.
——
The transaction also benefits from the support of strategic partner Groupe Cristal and the group’s banking partners: Crédit Lyonnais (Agent and Coordinator), Caisse Régionale de Crédit Agricole Mutuel de Centre France (Coordinator), Banque CIC Ouest, Banque Populaire Grand Ouest, BNP Paribas, CIC Lyonnaise de Banque, Banque Populaire Auvergne-Rhône-Alpes, Banque Populaire Rives De Paris, Bred Banque Populaire, Arkea Banque Entreprises et Institutionnels, and La Banque Postale.
Tips from Neftys Pharma
Neftys Pharma Team : Diego Mignot, Elisabeth Siachoua, Nicolas Lang. |
Tips from For Talents
For Talents Team : Benjamin Teszner, Mathieu Mousseron, and Sabine Decoster; Blandine Pessin-Bazil and Bertrand Cunaud. |
Advice from GENEO Capital Entrepreneur
GENEO Capital Entrepreneur Team : François Picarle and Diane Lajaumont |
Tips from UI Investment
UI Investissement Team: Stéphanie Pépineau, Olivier Jarrousse. |
About For Talents
Founded in 2021 by Matthieu Leclercq, former President of the family-owned company Decathlon and founder of O’Tera, For Talents is a family-owned investment firm dedicated to serving family-owned businesses. As a mission-driven company, it is the first investment firm specializing in the pivotal moment of succession between two generations of a family business. Its mission is to increase the success of generational transitions in family businesses.
For Talents has developed a unique approach that combines a minority investment with personalized support for executives and corporate governance, offering two investment options: one ranging from €30 million to €100 million, and another of €1 million for SMEs, in partnership with PurpleShares. To date, For Talents has invested approximately €800 million in 11 family-owned SMEs and mid-market companies: Paprec, Groupe Petit Forestier, Riou Glass, Altavia, Biografy, Cofinas, BelEnergia, Groupe GPA, Sud Express, Leman Industries, and Neftys Pharma. For Talents is comprised of 15 individuals with corporate backgrounds—experts who are dedicated and driven by shared values of trust, simplicity, and innovation.
More information: www.fortalents.com
About the Neftys Pharma Group
The NEFTYS PHARMA Group is a major player in the distribution of veterinary products. With a presence in more than 15 countries across Europe and Africa, Neftys Pharma is an independent French family-owned group that employs 730 people and generated revenue of €555 million in 2025. Its business is to distribute veterinary products across all distribution channels: veterinary clinics, pharmacies, livestock associations, garden centers, pet stores, and e-commerce.
More information: www.neftys-pharma.com
About GENEO Capital Entrepreneur
Through its investment firm “evergreen,” GENEO Capital Entrepreneur provides agile capital that adapts to the pace of each company with responsiveness and flexibility. As a business partner, it provides operational and human support for the execution of business plans through a customized “Growth Playbook” for each company, as well as access to specialized “business partners” and a network of experts. Its community of over 260 families and entrepreneurs offers a unique platform for sharing experiences and a business network unlike any other in France.
For more information: www.geneocapitalentrepreneur.com
About UI Investment
As an independent firm specializing in business development, UI has been working closely with the leaders of startups, small and medium-sized businesses, and mid-market companies for over 50 years to help them establish and grow economically and sustainably successful businesses.
UI Investissement manages more than €1.8 billion in assets and partners with over 300 business leaders in sectors critical to society, such as healthcare, agribusiness, industry, and services. Growth and succession capital, the historic core of UI’s business, accounts for more than half of assets under management and enables more than 80 companies to benefit from the operational expertise and methodological tools developed by UI.
At the same time, investment teams and funds dedicated to innovation and consolidation help support companies throughout their lifecycle and contribute to the economic vitality of local regions.
UI currently employs nearly 90 people and, in addition to its Paris-based teams, operates more than 10 regional offices (Besançon, Bordeaux, Clermont-Ferrand, Dijon, Lille, Limoges, Lyon, Nantes, Orléans, Reims, Rennes, Strasbourg).For more information: www.ui-investissement.fr
PRESS CONTACTS | TALENT CONTACTS
Antidox \ NSI Group, the ADIT Group’s influencer agency
Sabrina Russo – +33 6 82 92 94 45 I Ingrid Brégeon-Fall – +33 6 33 58 54 94
sabrina.russo@nsi-adit.com
PRESS CONTACT | GENEO Capital Entrepreneur
Bien Commun Advisory
Hugues de Tournemire – +33 6 67 07 22 33
geneo@bcadvisory.fr
PRESS CONTACT I UI Investissement
Laurent Maillard – +33 6 60 59 77 07
laurent.maillard@ui-investissement.fr
